This inventor holds 1 USPTO granted patent. Top assignee: Island Pharmaceuticals Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations in Gene Therapy by Peter Hofschneider
Introduction
Peter Hofschneider is a notable inventor based in Munich, Germany. He has made significant contributions to the field of gene therapy, particularly through his innovative patent related to particles designed for this purpose. His work is crucial in advancing therapeutic techniques that can potentially transform medical treatments.
Latest Patents
Hofschneider holds a patent for "Particles for gene therapy." This invention involves particles that consist of a protein envelope containing a fusion protein, which includes a virus protein, a cell permeability-mediating peptide, and a heterologous cell-specific binding site. Additionally, the nucleic acid present in the protein envelope comprises a sequence for a virus-specific packaging signal and a structural gene. The patent also outlines methods for preparing these particles and their applications in gene therapy.
Career Highlights
Peter Hofschneider has established himself as a key figure in the biotechnology sector. He is currently associated with Island Pharmaceuticals Ltd., where he continues to work on innovative solutions in gene therapy. His expertise and dedication to research have positioned him as a valuable contributor to advancements in this critical area of medicine.
Collaborations
Hofschneider collaborates with Eberhard Hildt, a fellow researcher in the field. Their partnership enhances the potential for groundbreaking discoveries and innovations in gene therapy.
Conclusion
Peter Hofschneider's work exemplifies the intersection of innovation and healthcare, particularly through his patent on gene therapy particles. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile